- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.84 Å
- Oligo State
- homo-tetramer
- Ligands
- 8 x CA: CALCIUM ION(Non-covalent)
- 4 x EF8: 6-[[(3~{R},4~{R},5~{S})-4-acetamido-5-azanyl-3-pentan-3-yloxy-cyclohexen-1-yl]-oxidanyl-phosphoryl]oxyhexylimino-azanylidene-azanium(Non-covalent)
EF8.3: 16 residues within 4Å:- Chain A: R.37, E.38, I.68, D.70, R.71, W.98, R.144, S.166, E.196, E.197, R.212, N.214, R.287, Y.321, R.349, P.350
14 PLIP interactions:14 interactions with chain A- Hydrophobic interactions: A:W.98, A:P.350
- Hydrogen bonds: A:R.37, A:R.37, A:E.38, A:R.71, A:R.212, A:R.212, A:R.287, A:R.287, A:R.349, A:R.349
- Water bridges: A:R.75, A:E.147
EF8.14: 16 residues within 4Å:- Chain B: R.37, E.38, I.68, D.70, R.71, W.98, R.144, S.166, E.196, E.197, R.212, N.214, R.287, Y.321, R.349, P.350
14 PLIP interactions:14 interactions with chain B- Hydrophobic interactions: B:W.98, B:P.350
- Hydrogen bonds: B:R.37, B:R.37, B:E.38, B:R.71, B:R.212, B:R.212, B:R.287, B:R.287, B:R.349, B:R.349
- Water bridges: B:R.75, B:E.147
EF8.25: 16 residues within 4Å:- Chain C: R.37, E.38, I.68, D.70, R.71, W.98, R.144, S.166, E.196, E.197, R.212, N.214, R.287, Y.321, R.349, P.350
14 PLIP interactions:14 interactions with chain C- Hydrophobic interactions: C:W.98, C:P.350
- Hydrogen bonds: C:R.37, C:R.37, C:E.38, C:R.71, C:R.212, C:R.212, C:R.287, C:R.287, C:R.349, C:R.349
- Water bridges: C:R.75, C:E.147
EF8.36: 16 residues within 4Å:- Chain D: R.37, E.38, I.68, D.70, R.71, W.98, R.144, S.166, E.196, E.197, R.212, N.214, R.287, Y.321, R.349, P.350
14 PLIP interactions:14 interactions with chain D- Hydrophobic interactions: D:W.98, D:P.350
- Hydrogen bonds: D:R.37, D:R.37, D:E.38, D:R.71, D:R.212, D:R.212, D:R.287, D:R.287, D:R.349, D:R.349
- Water bridges: D:R.75, D:E.147
- 12 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.4: 1 residues within 4Å:- Chain A: N.7
1 PLIP interactions:1 interactions with chain A- Water bridges: A:N.7
NAG.5: 2 residues within 4Å:- Chain A: N.65, I.355
3 PLIP interactions:2 interactions with chain A, 1 interactions with chain D- Hydrophobic interactions: A:I.355
- Water bridges: A:N.65, D:E.381
NAG.6: 2 residues within 4Å:- Chain A: N.305, F.306
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:F.306
- Hydrogen bonds: A:N.305, A:F.306
NAG.15: 1 residues within 4Å:- Chain B: N.7
1 PLIP interactions:1 interactions with chain B- Water bridges: B:N.7
NAG.16: 2 residues within 4Å:- Chain B: N.65, I.355
3 PLIP interactions:2 interactions with chain B, 1 interactions with chain C- Hydrophobic interactions: B:I.355
- Water bridges: B:N.65, C:E.381
NAG.17: 2 residues within 4Å:- Chain B: N.305, F.306
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:F.306
- Hydrogen bonds: B:N.305, B:F.306
NAG.26: 1 residues within 4Å:- Chain C: N.7
1 PLIP interactions:1 interactions with chain C- Water bridges: C:N.7
NAG.27: 2 residues within 4Å:- Chain C: N.65, I.355
3 PLIP interactions:2 interactions with chain C, 1 interactions with chain A- Hydrophobic interactions: C:I.355
- Water bridges: C:N.65, A:E.381
NAG.28: 2 residues within 4Å:- Chain C: N.305, F.306
3 PLIP interactions:3 interactions with chain C- Hydrophobic interactions: C:F.306
- Hydrogen bonds: C:N.305, C:F.306
NAG.37: 1 residues within 4Å:- Chain D: N.7
1 PLIP interactions:1 interactions with chain D- Water bridges: D:N.7
NAG.38: 2 residues within 4Å:- Chain D: N.65, I.355
3 PLIP interactions:2 interactions with chain D, 1 interactions with chain B- Hydrophobic interactions: D:I.355
- Water bridges: D:N.65, B:E.381
NAG.39: 2 residues within 4Å:- Chain D: N.305, F.306
3 PLIP interactions:3 interactions with chain D- Hydrophobic interactions: D:F.306
- Hydrogen bonds: D:N.305, D:F.306
- 20 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.7: 4 residues within 4Å:- Chain A: S.9, D.203, K.271, Y.272
Ligand excluded by PLIPEDO.8: 4 residues within 4Å:- Chain A: K.271, G.273, N.274, T.300
Ligand excluded by PLIPEDO.9: 6 residues within 4Å:- Chain A: N.65, G.66, T.67, K.69, S.72
- Chain D: R.26
Ligand excluded by PLIPEDO.10: 5 residues within 4Å:- Chain A: P.12, V.13, Y.272, W.277, W.294
Ligand excluded by PLIPEDO.11: 7 residues within 4Å:- Chain A: Y.19, L.46, E.47, C.48, I.82
- Chain C: N.128, G.129
Ligand excluded by PLIPEDO.18: 4 residues within 4Å:- Chain B: S.9, D.203, K.271, Y.272
Ligand excluded by PLIPEDO.19: 4 residues within 4Å:- Chain B: K.271, G.273, N.274, T.300
Ligand excluded by PLIPEDO.20: 6 residues within 4Å:- Chain B: N.65, G.66, T.67, K.69, S.72
- Chain C: R.26
Ligand excluded by PLIPEDO.21: 5 residues within 4Å:- Chain B: P.12, V.13, Y.272, W.277, W.294
Ligand excluded by PLIPEDO.22: 7 residues within 4Å:- Chain B: Y.19, L.46, E.47, C.48, I.82
- Chain D: N.128, G.129
Ligand excluded by PLIPEDO.29: 4 residues within 4Å:- Chain C: S.9, D.203, K.271, Y.272
Ligand excluded by PLIPEDO.30: 4 residues within 4Å:- Chain C: K.271, G.273, N.274, T.300
Ligand excluded by PLIPEDO.31: 6 residues within 4Å:- Chain A: R.26
- Chain C: N.65, G.66, T.67, K.69, S.72
Ligand excluded by PLIPEDO.32: 5 residues within 4Å:- Chain C: P.12, V.13, Y.272, W.277, W.294
Ligand excluded by PLIPEDO.33: 7 residues within 4Å:- Chain B: N.128, G.129
- Chain C: Y.19, L.46, E.47, C.48, I.82
Ligand excluded by PLIPEDO.40: 4 residues within 4Å:- Chain D: S.9, D.203, K.271, Y.272
Ligand excluded by PLIPEDO.41: 4 residues within 4Å:- Chain D: K.271, G.273, N.274, T.300
Ligand excluded by PLIPEDO.42: 6 residues within 4Å:- Chain B: R.26
- Chain D: N.65, G.66, T.67, K.69, S.72
Ligand excluded by PLIPEDO.43: 5 residues within 4Å:- Chain D: P.12, V.13, Y.272, W.277, W.294
Ligand excluded by PLIPEDO.44: 7 residues within 4Å:- Chain A: N.128, G.129
- Chain D: Y.19, L.46, E.47, C.48, I.82
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kozisek, M. et al., DNA-linked inhibitor antibody assay (DIANA) as a new method for screening influenza neuraminidase inhibitors. Biochem. J. (2018)
- Release Date
- 2019-01-23
- Peptides
- Neuraminidase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
BC
BD
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.84 Å
- Oligo State
- homo-tetramer
- Ligands
- 8 x CA: CALCIUM ION(Non-covalent)
- 4 x EF8: 6-[[(3~{R},4~{R},5~{S})-4-acetamido-5-azanyl-3-pentan-3-yloxy-cyclohexen-1-yl]-oxidanyl-phosphoryl]oxyhexylimino-azanylidene-azanium(Non-covalent)
- 12 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 20 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kozisek, M. et al., DNA-linked inhibitor antibody assay (DIANA) as a new method for screening influenza neuraminidase inhibitors. Biochem. J. (2018)
- Release Date
- 2019-01-23
- Peptides
- Neuraminidase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
BC
BD
B